Prediction of poststroke hemorrhagic transformation using computed tomography perfusion

Stroke

Volumn 44, Issue 11, 2013, Pages 3039-3043

  Yassi, Nawaf ^a   Parsons, Mark W ^b   Christensen, Søren ^a   Sharma, Gagan ^a   Bivard, Andrew ^a   Donnan, Geoffrey A ^a   Levi, Christopher R ^b   Desmond, Patricia M ^a   Davis, Stephen M ^a   Campbell, Bruce C V ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Acute; Diagnostic; Functional; Imaging; Magnetic resonance imaging; Multislice computed tomography; Perfusion; Stroke; Therapeutic; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT; IOPROMIDE; PLACEBO; WARFARIN;

AGED; AREA UNDER THE CURVE; ARTICLE; BAYES THEOREM; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN RADIOGRAPHY; CARDIOVASCULAR RISK; CEREBRAL PARENCHYMAL HEMATOMA; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED SCINTIGRAPHY; COMPUTER ASSISTED TOMOGRAPHY PERFUSION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; FOLLOW UP; HEMORRHAGIC TRANSFORMATION; HUMAN; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

IMAGING, DIAGNOSTIC; MAGNETIC RESONANCE IMAGING, FUNCTIONAL; MULTISLICE COMPUTED TOMOGRAPHY; PERFUSION; STROKE, ACUTE; THROMBOLYSIS, THERAPEUTIC;

AGED; AGED, 80 AND OVER; BAYES THEOREM; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PERFUSION; REGRESSION ANALYSIS; ROC CURVE; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84888221963     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002396     Document Type: Article

References (40)

1. Lees KR, Bluhmki E, Von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke. Lancet. 2010;375:1695.
2. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:581-1587.
3. Hacke W, Kaste M, Fieschi C, Von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352:1245-1251.
4. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study. J Am Med Assoc. 1999;282:2019-2026.
5. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (Alteplase) 0- to 6-Hour Acute Stroke Trial, Part A (A0276g). Stroke. 2000;31:811-816.
6. Hacke W, Donnan G, Fieschi C, Kaste M, Von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment. Lancet. 2004;363:768-774.
7. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Lancet Neurology. 2008;7:299-309.
8. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
9. Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase Safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012;43:1524-1531.
10. Menon BK, Saver JL, Prabhakaran S, Reeves M, Liang L, Olson DM, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012;43:2293-2299.
11. Strbian D, Engelter S, Michel P, Meretoja A, Sekoranja L, Ahlhelm FJ, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol. 2012;71:634-641.
12. Nadeau JO, Shi S, Fang J, Kapral MK, Richards JA, Silver FL, et al; Investigators for the Registry of the Canadian Stroke Network. TPA use for stroke in the Registry of the Canadian Stroke Network. Can J Neurol Sci. 2005;32:433-439.
13. Wahlgren N, Ahmed N, Dávalos A, Hacke W, Millán M, Muir K, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR). Lancet. 2008;372:1303-1309.
14. The NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28:2109-2118.
15. Tanne D. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice. Circulation. 2002;105:1679-1685.
16. Derex L, Hermier M, Adeleine P, Pialat JB, Wiart M, Berthezène Y, et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry. 2005;76:70-75.
17. Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke. Cerebrovasc Dis. 2007;24:1-10.
18. Butcher K, Christensen S, Parsons M, De Silva DA, Ebinger M, Levi C, et al; EPITHET Investigators. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke. 2010;41:72-77.
19. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, et al; MR Stroke Study Group Investigators. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusionweighted magnetic resonance imaging. Ann Neurol. 2008;63:52-60.
20. Mlynash M, Lansberg MG, De Silva DA, Lee J, Christensen S, Straka M, et al. Refining the definition of the malignant profile insights from the DEFUSE-EPITHET pooled data set. Stroke. 2011;42:1270-1275.
21. Campbell BC, Christensen S, Butcher KS, Gordon I, Parsons MW, Desmond PM, et al; EPITHET Investigators. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusionweighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke. 2010;41:82-88.
22. Campbell BC, Christensen S, Parsons MW, Churilov L, Desmond PM, Barber PA, et al. Advanced imaging improves prediction of hemorrhage after stroke thrombolysis. Ann Neurol. 2013;73:510-519.
23. Bang OY, Buck BH, Saver JL, Alger JR, Yoon SR, Starkman S, et al. Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol. 2007;62:170-176.
24. Souza LC, Payabvash S, Wang Y, Kamalian S, Schaefer P, Gonzalez RG, et al. Admission CT perfusion is an independent predictor of hemorrhagic transformation in acute stroke with similar accuracy to DWI. Cerebrovasc Dis. 2012;33:8-15.
25. Jain AR, Jain M, Kanthala AR, Damania D, Stead LG, Wang HZ, et al. Association of CT perfusion parameters with hemorrhagic transformation in acute ischemic stroke. AJNR Am J Neuroradiol. April 18, 2013. doi:10.3174/ajnr. A3502.: http://www.ajnr.org/content/early/2013/04/18/ajnr. A3502.full.pdf+html. Accessed April 29, 2013.
26. Shinoyama M, Nakagawara J, Yoneda H, Suzuki M, Ono H, Kunitsugu I, et al. Initial 'TTP Map-Defect' of Computed Tomography Perfusion as a Predictor of Hemorrhagic Transformation of Acute Ischemic Stroke. Cerebrovasc Dis Extra. 2013;3:14-25.
27. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, et al. Early hemorrhagic transformation of brain infarction. Stroke. 2008;39:2249-2256.
28. Wintermark M, Lau BC, Chien J, Arora S. The anterior cerebral artery is an appropriate arterial input function for perfusion-CT processing in patients with acute stroke. Neuroradiology. 2008;50:227-236.
29. Mouridsen K, Christensen S, Gyldensted L, Ostergaard L. Automatic selection of arterial input function using cluster analysis. Magn Reson Med. 2006;55:524-531.
30. Renou P, Sibon I, Tourdias T, Rouanet F, Rosso C, Galanaud D, et al. Reliability of the ECASS radiological classification of postthrombolysis brain haemorrhage. Cerebrovasc Dis. 2010;29:597-604.
31. Raftery AE. Bayesian model selection in social research. In: Marsden P V, ed. Sociological Methodology. Oxford: Blackwell; 1996:111-163.
32. Campbell BC, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, et al. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke. 2011;42:3435-3440.
33. Kim JH, Bang OY, Liebeskind DS, Ovbiagele B, Kim GM, Chung CS, et al; UCLA-Samsung Stroke Collaborators. Impact of baseline tissue status (diffusion-weighted imaging lesion) versus perfusion status (severity of hypoperfusion) on hemorrhagic transformation. Stroke. 2010;41:e135-e142.
34. Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008;71:1417-1423.
35. Larrue V, Von Kummer R R, Müller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32:438-441.
36. Sandercock P, Wardlaw J, Lindley R, Dennis M, Cohen G, Murray G, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (IST-3). Lancet. 2012;379:2352-2363.
37. Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke. 1999;30:1528-1533.
38. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol. 2004;56:468-477.
39. Martínez-Hernández E, Martínez-Ramírez S, Delgado-Mederos R, Alcolea D, Marquié M, Marín R, et al. Remote cerebral hematomas in patients treated with intravenous rt-PA. J Neurol. 2010;257:1062-1066.
40. Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke. Stroke. 2010;41:2254-2258.